We are exploring how amyloid PET imaging may improve care for people with dementia compared to standard diagnostic methods. This study aims to show its impact on important health outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Dementia is a general term for a decline in cognitive function that affects daily living. It includes various types such as Alzheimer's disease, vascular dementia, and mixed dementia, leading to symptoms like memory loss, confusion, and difficulty with communication.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.